The risk of gastrointestinal perforation and/or fistula in patients with recurrent ovarian cancer receiving bevacizumab compared to standard chemotherapy: a retrospective cohort study (Q37529990)
Jump to navigation
Jump to search
scientific article published on 23 June 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The risk of gastrointestinal perforation and/or fistula in patients with recurrent ovarian cancer receiving bevacizumab compared to standard chemotherapy: a retrospective cohort study |
scientific article published on 23 June 2009 |
Statements
1 reference
The risk of gastrointestinal perforation and/or fistula in patients with recurrent ovarian cancer receiving bevacizumab compared to standard chemotherapy: a retrospective cohort study (English)
1 reference
Gregory P Sfakianos
1 reference
T Michael Numnum
1 reference
Caitlin B Halverson
1 reference
Deepa Panjeti
1 reference
James E Kendrick
1 reference
J Michael Straughn
1 reference
23 June 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference